CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-30 | Mitchener Stephen SVP, Chief Business Officer | Exercise or conversion · Restricted Stock Units | −1,500 | 1,500 | ||
| 2021-05-21 | Schor Chen Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2021-05-21 | PAKIANATHAN DEEPIKA Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2021-05-21 | Oliger Christy J. Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2021-05-21 | Mirza Mansoor Raza Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2021-05-21 | Greene Barry E Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2021-05-21 | Dolsten Mikael Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2021-05-21 | BOHLIN GAREN G Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2021-05-07 | Shah Jatin EVP, Chief Medical Officer | Purchase | +23,250 | $8.60 | $200K | 131,802 |
| 2021-05-06 | BOHLIN GAREN G Director | Purchase | +4,000 | $7.82 | $31K | 4,000 |
| 2021-05-03 | Paulson Richard A. President and CEO | Grant or award | +373,200 | 373,200 | ||
| 2021-05-03 | Paulson Richard A. President and CEO | Grant or award · Stock Option (right to buy) | +559,800 | 559,800 | ||
| 2021-03-18 | Shacham Sharon President & CSO | Sale | −4,000 | $12.39 | $50K | 714,826 |
| 2021-03-18 | Kauffman Michael Chief Executive Officer | Sale | −4,000 | $12.39 | $50K | 714,826 |
| 2021-02-25 | Shah Jatin EVP, Chief Medical Officer | Grant or award | +22,013 | 107,691 | ||
| 2021-02-25 | Shah Jatin EVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +59,968 | 59,968 | ||
| 2021-02-25 | Mason Michael SVP, CFO & Treasurer | Grant or award | +22,013 | 51,755 | ||
| 2021-02-25 | Mason Michael SVP, CFO & Treasurer | Grant or award · Stock Option (right to buy) | +59,968 | 59,968 | ||
| 2021-02-25 | Lewis Tanya EVP, Chief Reg. Affairs | Grant or award | +22,013 | 45,401 | ||
| 2021-02-25 | Lewis Tanya EVP, Chief Reg. Affairs | Grant or award · Stock Option (right to buy) | +59,968 | 59,968 |
Page 16 of 29 · 570 trades